Genetic engineering can make immune cells resistant to infection with human or monkey (simian) immunodeficiency virus (HIV and SIV, respectively). Recently, treatment with HIV-resistant immune cells has given encouraging ...
Mar 31, 2022
0
59
Though it has been eclipsed lately by SARS-CoV-2, there is another global epidemic still threatening people: HIV/AIDS. According to UNAIDS, a United Nations initiative, some 38 million people worldwide are currently infected ...
Mar 29, 2022
0
822
While scientists have made unprecedented progress in preventing COVID-19 in the past two years, they have also moved closer to finding a vaccine to protect against the human immunodeficiency virus (HIV), which has been infecting ...
Mar 11, 2022
0
5
A regional corner of Africa is a hotspot for cases of HIV, tuberculosis and malaria, prompting researchers to call for targeted health support rather than a national response.
Feb 25, 2022
0
9
New research sheds light on the lifespans and location of the cells that are responsible for producing HIV, preventing its eradication. Understanding the cells' dynamics may help scientists develop new ways to reduce their ...
Feb 3, 2022
0
48
As the ongoing coronavirus pandemic has demonstrated, new mutations in viral genetic sequences can have significant impacts on the virus's transmissibility and the damage it causes. For many years, there have been concerns ...
Feb 3, 2022
0
201
A team of researchers at the Chinese Academy of Medical Science has found that a fatty molecule they created worked effectively against a monkey version of HIV. In their paper published in the journal Cell, the group describes ...
HIV replication in the human body requires that specific viral RNAs be packaged into progeny virus particles. A new study has found how a small difference in the RNA sequence can allow the viral RNA to be packaged for replication, ...
Dec 15, 2021
0
76
An experimental HIV vaccine based on mRNA—the same technology used in two highly successful COVID-19 vaccines—has shown promise in experiments in mice and monkeys, according to a study published Thursday in Nature Medicine.
Dec 12, 2021
0
153
The first long-acting option to protect women from HIV, proven to reduce women's HIV risk, has been recommended for use by the World Health Organization (WHO).
Dec 1, 2021
0
1
